NCT00244101View on ClinicalTrials.gov

Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

648

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2011

Conditions

Respiratory Distress Syndrome, Newborn

Interventions

DRUG

PS Group

Intubation, prophylactic surfactant administration shortly after delivery, and subsequent stabilization on ventilator support.

DEVICE

NCPAP Group

Early stabilization on nasal continuous positive airway pressure (NCPAP) with selected intubation and surfactant administration for clinical indications.

DRUG

ISX Group

Intubation, prophylactic surfactant administration shortly after delivery, and rapid extubation to nasal CPAP.

Trial Locations (1)

05401

Vermont Oxford Network, Burlington

All Listed Sponsors

lead

Vermont Oxford Network

NETWORK

NCT00244101 - Delivery Room Management Trial of Premature Infants at High Risk of Respiratory Distress Syndrome | Biotech Hunter | Biotech Hunter